Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196.HK)
HKD 13.98
(1.16%)
HKD 13.98
(1.16%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 16.49 Billion CNY | 6.39% |
| 2022 | 17.14 Billion CNY | 6.78% |
| 2021 | 16.05 Billion CNY | 14.31% |
| 2020 | 14.04 Billion CNY | -2.63% |
| 2019 | 14.42 Billion CNY | 18.38% |
| 2018 | 12.18 Billion CNY | 41.35% |
| 2017 | 8.62 Billion CNY | 39.76% |
| 2016 | 6.16 Billion CNY | 27.79% |
| 2015 | 4.82 Billion CNY | 17.32% |
| 2014 | 4.11 Billion CNY | 23.22% |
| 2013 | 3.33 Billion CNY | 27.43% |
| 2012 | 2.62 Billion CNY | 21.94% |
| 2011 | 2.14 Billion CNY | 54.1% |
| 2010 | 1.39 Billion CNY | 26.99% |
| 2009 | 1.09 Billion CNY | 16.86% |
| 2008 | 939.7 Million CNY | 12.61% |
| 2007 | 834.46 Million CNY | 5.02% |
| 2006 | 794.58 Million CNY | -4.21% |
| 2005 | 829.47 Million CNY | 26.02% |
| 2004 | 658.2 Million CNY | 19.81% |
| 2003 | 549.38 Million CNY | 80.65% |
| 2002 | 304.11 Million CNY | 47.01% |
| 2001 | 206.86 Million CNY | 20.05% |
| 2000 | 172.31 Million CNY | 68.52% |
| 1999 | 102.25 Million CNY | 63.33% |
| 1998 | 62.6 Million CNY | 98.18% |
| 1997 | 31.58 Million CNY | 121.4% |
| 1996 | 14.26 Million CNY | 191.04% |
| 1995 | 4.9 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 4.11 Billion CNY | 0.9% |
| 2024 Q3 | 4.15 Billion CNY | -6.68% |
| 2024 Q1 | 4.08 Billion CNY | -14.86% |
| 2023 FY | 18.24 Billion CNY | 6.39% |
| 2023 Q1 | 4.47 Billion CNY | -15.14% |
| 2023 Q2 | 4.7 Billion CNY | 4.94% |
| 2023 Q3 | 4.26 Billion CNY | -9.29% |
| 2023 Q4 | 4.79 Billion CNY | 12.47% |
| 2022 Q4 | 5.27 Billion CNY | 24.26% |
| 2022 Q1 | 3.66 Billion CNY | -20.15% |
| 2022 Q2 | 3.95 Billion CNY | 8.1% |
| 2022 Q3 | 4.24 Billion CNY | 7.34% |
| 2022 FY | 17.14 Billion CNY | 6.78% |
| 2021 Q1 | 3.46 Billion CNY | -12.65% |
| 2021 Q2 | 3.9 Billion CNY | 12.57% |
| 2021 Q3 | 4.1 Billion CNY | 5.28% |
| 2021 Q4 | 4.58 Billion CNY | 11.64% |
| 2021 FY | 16.05 Billion CNY | 14.31% |
| 2020 Q3 | 3.71 Billion CNY | 2.5% |
| 2020 Q2 | 3.62 Billion CNY | 32.77% |
| 2020 Q4 | 3.96 Billion CNY | 6.66% |
| 2020 Q1 | 2.73 Billion CNY | -30.57% |
| 2020 FY | 14.04 Billion CNY | -2.63% |
| 2019 FY | 14.42 Billion CNY | 18.38% |
| 2019 Q3 | 3.49 Billion CNY | -7.15% |
| 2019 Q2 | 3.76 Billion CNY | 16.92% |
| 2019 Q4 | 3.93 Billion CNY | 12.49% |
| 2019 Q1 | 3.22 Billion CNY | -6.45% |
| 2018 Q2 | 3 Billion CNY | 18.82% |
| 2018 Q4 | 3.44 Billion CNY | 7.76% |
| 2018 FY | 12.18 Billion CNY | 41.35% |
| 2018 Q1 | 2.53 Billion CNY | -10.84% |
| 2018 Q3 | 3.19 Billion CNY | 6.22% |
| 2017 Q4 | 2.84 Billion CNY | 28.38% |
| 2017 Q3 | 2.21 Billion CNY | 13.68% |
| 2017 Q1 | 1.61 Billion CNY | -15.5% |
| 2017 FY | 8.62 Billion CNY | 39.76% |
| 2017 Q2 | 1.94 Billion CNY | 20.18% |
| 2016 Q2 | 1.48 Billion CNY | 20.96% |
| 2016 FY | 6.16 Billion CNY | 27.79% |
| 2016 Q4 | 1.91 Billion CNY | 24.36% |
| 2016 Q3 | 1.54 Billion CNY | 3.91% |
| 2016 Q1 | 1.22 Billion CNY | -11.07% |
| 2015 FY | 4.82 Billion CNY | 17.32% |
| 2015 Q4 | 1.37 Billion CNY | 13.36% |
| 2015 Q3 | 1.21 Billion CNY | 3.04% |
| 2015 Q2 | 1.18 Billion CNY | 12.37% |
| 2015 Q1 | 1.05 Billion CNY | -15.87% |
| 2014 FY | 4.11 Billion CNY | 23.22% |
| 2014 Q4 | 1.24 Billion CNY | 21.21% |
| 2014 Q3 | 1.03 Billion CNY | 9.2% |
| 2014 Q2 | 943.7 Million CNY | 5.88% |
| 2014 Q1 | 891.32 Million CNY | -7.86% |
| 2013 Q2 | 826.58 Million CNY | 18.12% |
| 2013 FY | 3.33 Billion CNY | 27.43% |
| 2013 Q1 | 699.78 Million CNY | -5.71% |
| 2013 Q3 | 845.37 Million CNY | 2.27% |
| 2013 Q4 | 967.33 Million CNY | 14.43% |
| 2012 Q1 | 591.65 Million CNY | -14.43% |
| 2012 Q2 | 659.36 Million CNY | 11.44% |
| 2012 Q4 | 742.19 Million CNY | 18.33% |
| 2012 FY | 2.62 Billion CNY | 21.94% |
| 2012 Q3 | 627.22 Million CNY | -4.87% |
| 2011 Q3 | 515.65 Million CNY | 3.56% |
| 2011 Q1 | 444.06 Million CNY | 8.27% |
| 2011 Q2 | 497.91 Million CNY | 12.13% |
| 2011 FY | 2.14 Billion CNY | 54.1% |
| 2011 Q4 | 691.4 Million CNY | 34.08% |
| 2010 FY | 1.39 Billion CNY | 26.99% |
| 2010 Q1 | 293.96 Million CNY | -7.04% |
| 2010 Q3 | 351.36 Million CNY | 3.62% |
| 2010 Q2 | 339.08 Million CNY | 15.35% |
| 2010 Q4 | 410.12 Million CNY | 16.73% |
| 2009 Q2 | 259.06 Million CNY | 4.66% |
| 2009 Q4 | 316.23 Million CNY | 14.86% |
| 2009 Q3 | 275.33 Million CNY | 6.28% |
| 2009 Q1 | 247.52 Million CNY | -10.39% |
| 2009 FY | 1.09 Billion CNY | 16.86% |
| 2008 Q4 | 276.22 Million CNY | 14.73% |
| 2008 Q3 | 240.74 Million CNY | 9.44% |
| 2008 Q2 | 219.98 Million CNY | 8.5% |
| 2008 Q1 | 202.75 Million CNY | -8.39% |
| 2008 FY | 939.7 Million CNY | 12.61% |
| 2007 Q2 | 194.31 Million CNY | 1.56% |
| 2007 FY | 834.46 Million CNY | 5.02% |
| 2007 Q4 | 221.32 Million CNY | -2.71% |
| 2007 Q1 | 191.33 Million CNY | -21.62% |
| 2007 Q3 | 227.48 Million CNY | 17.07% |
| 2006 Q1 | 187.41 Million CNY | -36.21% |
| 2006 Q2 | 185.52 Million CNY | -1.01% |
| 2006 Q3 | 177.53 Million CNY | -4.31% |
| 2006 Q4 | 244.11 Million CNY | 37.5% |
| 2006 FY | 794.58 Million CNY | -4.21% |
| 2005 Q3 | 153.91 Million CNY | -18.22% |
| 2005 Q4 | 293.82 Million CNY | 90.89% |
| 2005 Q1 | 193.52 Million CNY | 45.67% |
| 2005 FY | 829.47 Million CNY | 26.02% |
| 2005 Q2 | 188.2 Million CNY | -2.75% |
| 2004 FY | 658.2 Million CNY | 19.81% |
| 2004 Q4 | 132.85 Million CNY | -36.7% |
| 2004 Q1 | 169.72 Million CNY | -4.79% |
| 2004 Q2 | 145.74 Million CNY | -14.12% |
| 2004 Q3 | 209.87 Million CNY | 44.0% |
| 2003 Q4 | 178.25 Million CNY | 26.78% |
| 2003 Q3 | 140.6 Million CNY | 26.95% |
| 2003 Q2 | 110.75 Million CNY | -7.53% |
| 2003 Q1 | 119.77 Million CNY | 67.53% |
| 2003 FY | 549.38 Million CNY | 80.65% |
| 2002 Q3 | 88.31 Million CNY | -4.86% |
| 2002 Q2 | 92.83 Million CNY | 80.34% |
| 2002 Q1 | 51.47 Million CNY | 0.0% |
| 2002 Q4 | 71.49 Million CNY | -19.05% |
| 2002 FY | 304.11 Million CNY | 47.01% |
| 2001 FY | 206.86 Million CNY | 20.05% |
| 2000 FY | 172.31 Million CNY | 68.52% |
| 1999 FY | 102.25 Million CNY | 63.33% |
| 1998 FY | 62.6 Million CNY | 98.18% |
| 1997 FY | 31.58 Million CNY | 121.4% |
| 1996 FY | 14.26 Million CNY | 191.04% |
| 1995 FY | 4.9 Million CNY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 24.42 Million HKD | -67443.084% |
| Grand Pharmaceutical Group Limited | 3.86 Billion HKD | -327.302% |
| Extrawell Pharmaceutical Holdings Limited | 35.52 Million HKD | -46334.326% |
| Wai Yuen Tong Medicine Holdings Limited | 353.93 Million HKD | -4560.973% |
| Qianhai Health Holdings Limited | 17.1 Million HKD | -96360.782% |
| Lee's Pharmaceutical Holdings Limited | 590.99 Million HKD | -2691.361% |
| Essex Bio-Technology Limited | 1.22 Billion HKD | -1242.328% |
| Tongfang Kontafarma Holdings Limited | 503.46 Million HKD | -3176.651% |
| PuraPharm Corporation Limited | 216.62 Million HKD | -7515.196% |
| SSY Group Limited | 1.98 Billion HKD | -732.857% |
| JBM (Healthcare) Limited | 163.87 Million HKD | -9966.589% |
| Jacobson Pharma Corporation Limited | 287.34 Million HKD | -5641.006% |
| China Resources Pharmaceutical Group Limited | 29.35 Billion HKD | 43.801% |